Literature DB >> 9119445

Effects of essential fatty acid deficiency on prostaglandin E2 production and cell-mediated immunity in a mouse model of leprosy.

L B Adams1, T P Gillis, D H Hwang, J L Krahenbuhl.   

Abstract

Results from animal and in vitro studies suggest that essential fatty acid (EFA) deficiency enhances cell-mediated immunity by reducing production of prostaglandins with immunosuppressive actions. However, direct experimental evidence that EFA deficiency enhances T-lymphocyte function in vivo has not been obtained. In this study, athymic (nu/nu) mice were infected in the footpads with Mycobacterium leprae and fed a linoleic acid-free diet. These mice, and infected nu/nu mice on control diets, were given an adoptive transfer of M. leprae-primed, T-cell-enriched lymphocytes. After 2 weeks, M. leprae bacilli were harvested from the recipient mice and bacterial viability was determined by the BACTEC system. M. leprae recovered from recipient mice fed control diets displayed little reduction in metabolic activity. In contrast, M. leprae from recipient mice fed the EFA-deficient (EFAD) diet exhibited markedly reduced viability. In vitro, donor cells from M. leprae-primed mice secreted elevated levels of gamma interferon upon exposure to the bacilli. These cells also exhibited an enhanced proliferative response, which was reduced by exogenous prostaglandin E2 (PGE2). In addition, M. leprae-infected granuloma macrophages (Mphi) from EFAD recipient nu/nu mice secreted significantly less PGE2 than granuloma Mphi from mice on control diets. These data suggest that enhanced levels of Mphi-generated PGE2, induced by M. leprae or its constituents, could act as an endogenous negative modulator of the immune response occurring in the microenvironment of the lepromatous granuloma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119445      PMCID: PMC175111          DOI: 10.1128/iai.65.4.1152-1157.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Suppression of antigen and mitogen induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins.

Authors:  J J Ellner; P J Spagnuolo
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

2.  Lepromin-induced suppressor cells in patients with leprosy.

Authors:  V Mehra; L H Mason; J P Fields; B R Bloom
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Reduced exudation and increased tissue proliferation during chronic inflammation in rats deprived of endogenous prostaglandin precursors.

Authors:  I L Bonta; M J Parnham; M J Adolfs
Journal:  Prostaglandins       Date:  1977-08

4.  Characterization of the effects of endotoxin on macrophage tumor cell killing.

Authors:  J B Weinberg; H A Chapman; J B Hibbs
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

5.  A method for counting acid-fast bacteria.

Authors:  C C Shepard; D H McRae
Journal:  Int J Lepr Other Mycobact Dis       Date:  1968 Jan-Mar

6.  Lepromatoid lesion developed in nude mouse inoculated with Mycobacterium leprae--animal transmission of leprosy.

Authors:  K Kohsaka; T Mori; T Ito
Journal:  Repura       Date:  1976 Jul-Sep

7.  The effect of prostaglandin precursors in in vivo models of cell-mediated immunity.

Authors:  A Stackpoole; J Mertin
Journal:  Prog Lipid Res       Date:  1981       Impact factor: 16.195

8.  Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.

Authors:  T Godal; B Myklestad; D R Samuel; B Myrvang
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

9.  Decreased formation of porstaglandins derived from arachidonic acid by dietary linolenate in rats.

Authors:  D H Hwang; A E Carroll
Journal:  Am J Clin Nutr       Date:  1980-03       Impact factor: 7.045

10.  Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.

Authors:  J L Pace; S W Russell; B A Torres; H M Johnson; P W Gray
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

View more
  3 in total

1.  Vaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.

Authors:  Vanitha S Raman; Joanne O'Donnell; H Remy Bailor; Wakako Goto; Ramanuj Lahiri; Thomas P Gillis; Steven G Reed; Malcolm S Duthie
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

2.  Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse ear.

Authors:  Malcolm S Duthie; Stephen T Reece; Ramanuj Lahiri; Wakako Goto; Vanitha S Raman; Juliette Kaplan; Greg C Ireton; Sylvie Bertholet; Thomas P Gillis; James L Krahenbuhl; Steven G Reed
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

3.  Metabonomics reveals drastic changes in anti-inflammatory/pro-resolving polyunsaturated fatty acids-derived lipid mediators in leprosy disease.

Authors:  Julio J Amaral; Luis Caetano M Antunes; Cristiana S de Macedo; Katherine A Mattos; Jun Han; Jingxi Pan; André L P Candéa; Maria das Graças M O Henriques; Marcelo Ribeiro-Alves; Christoph H Borchers; Euzenir N Sarno; Patrícia T Bozza; B Brett Finlay; Maria Cristina V Pessolani
Journal:  PLoS Negl Trop Dis       Date:  2013-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.